Production (Stage)
InterCure Ltd.
INCR
$1.52
$0.021.33%
NASDAQ
| 12/31/2024 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 0.14% | -30.08% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.14% | -30.08% | |||
| Cost of Revenue | 0.14% | -22.39% | |||
| Gross Profit | 0.19% | -46.29% | |||
| SG&A Expenses | 0.14% | -12.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.14% | 22.44% | |||
| Total Operating Expenses | 0.14% | -19.15% | |||
| Operating Income | -0.14% | -210.95% | |||
| Income Before Tax | -0.14% | -7,774.12% | |||
| Income Tax Expenses | -0.14% | 157.05% | |||
| Earnings from Continuing Operations | -0.14% | -981.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.15% | -87.62% | |||
| Net Income | -0.14% | -769.41% | |||
| EBIT | -0.14% | -210.95% | |||
| EBITDA | 0.65% | -151.60% | |||
| EPS Basic | -0.14% | -846.27% | |||
| Normalized Basic EPS | -0.15% | -- | |||
| EPS Diluted | -0.09% | -846.27% | |||
| Normalized Diluted EPS | -0.15% | -- | |||
| Average Basic Shares Outstanding | 0.00% | -10.15% | |||
| Average Diluted Shares Outstanding | 0.00% | -10.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||